Trophic Factor Production by Glial Cells in the Treatment of Amyotrophic Lateral Sclerosis
Journal: Austin Journal of Biomedical Engineering (Vol.1, No. 5)Publication Date: 2014-09-10
Authors : Dennys CN; Franco MC; Estévez AG;
Page : 1-8
Keywords : Amyotrophic lateral sclerosis; Astrocytes; Microglia; Trophic factors;
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with unknown pathogenic causes. The identification of mutated genes in familial forms of ALS has lead to the development of animal models to study the mechanisms of motor neuron death. Transgenic animal models and human patients show that glutamate excitotoxicity, oxidative stress, protein aggregation and inflammation are hallmarks of the disease. Here we discuss the role of activated glial cells, specifically astrocytes and microglia on the disease pathogenesis and progression. Additionally, we discuss the current evidence showing that the induction of trophic factor production by glial cells may be an effective therapeutic strategy for the treatment of ALS.
Other Latest Articles
- Surgical Glue: A Brief Overview
- A Biomimetic Reverse Thermal Gel for 3-Dimensional Neural Tissue Engineering
- Identifying Gene Signatures Associated with Cancer Stem Cells and Drug Resistance from Triple Negative Breast Cancer Cells after Gene Targeting Treatment
- Profiling Protein-Protein Interactions and Protein Structures Using Chemical Cross-linking and Mass Spectrometry
- ANALYSIS OF GOVERNMENT REGULATION IN THE TRANSPORT INDUSTRY IN THE REPUBLIC OF KAZAKHSTAN
Last modified: 2016-08-11 20:57:33